Cargando…
Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
Cystic fibrosis–related diabetes (CFRD) is among the most common extrapulmonary co-morbidity associated with cystic fibrosis (CF), affecting an estimated 50% of adults with the condition. Cystic fibrosis is prevalent in 1 in every 2500 Caucasian live births and is caused by a mutation in the cystic...
Autores principales: | Kelsey, Ryan, Manderson Koivula, Fiona N, McClenaghan, Neville H, Kelly, Catriona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539575/ https://www.ncbi.nlm.nih.gov/pubmed/31191067 http://dx.doi.org/10.1177/1179551419851770 |
Ejemplares similares
-
Islet-intrinsic effects of CFTR mutation
por: Koivula, Fiona N. Manderson, et al.
Publicado: (2016) -
Stem Cell-Based Approaches for the Treatment of Diabetes
por: Kelly, Catriona, et al.
Publicado: (2011) -
Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
por: Gardner, Aaron I, et al.
Publicado: (2019) -
Short-term CFTR inhibition reduces islet area in C57BL/6 mice
por: Khan, Dawood, et al.
Publicado: (2019) -
COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021)